Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Soussi

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|March 7, 2022
Landscape of TP53 Alterations in Chronic Lymphocytic Leukemia <i>via</i> Data Mining Mutation DatabasesThierry Soussi, Panagiotis Baliakas
Journal of Internal Medicine|June 17, 2025
The TP53 tumor suppressor gene: From molecular biology to clinical investigationsPanagiotis Baliakas, Thierry Soussi
Trends in Cell Biology|November 22, 2016
TP53 and 53BP1 ReunitedThierry Soussi, Guido Kroemer
Trends in Molecular Medicine|December 23, 2008
When mutant p53 plays hide and seek: a new challenge for diagnosis and therapy?Thierry Soussi, Linn Hjortsberg
Cancer Cell|October 16, 2007
Shaping genetic alterations in human cancer: the p53 mutation paradigmThierry Soussi, Klas G Wiman
Human Mutation|March 26, 2014
TP53 mutations in human cancer: database reassessment and prospects for the next decadeBernard Leroy, Martha Anderson, Thierry Soussi
The FEBS Journal|June 30, 2009
Investigation and prediction of the severity of p53 mutants using parameters from structural calculationsJonas Carlsson, Thierry Soussi, Bengt Persson
Oncogene|August 7, 2003
Data mining the p53 pathway in the Fugu genome: evidence for strong conservation of the apoptotic pathwayMorgane Le Bras, Karim Bensaad, Thierry Soussi
Cell Death and Differentiation|October 24, 2024
TP53: the unluckiest of genes?Andreas C Joerger, Thorsten Stiewe, Thierry Soussi
Lung Cancer (Amsterdam, Netherlands)|March 1, 2003
Serum p53 antibodies in patients with lung cancer: correlation with clinicopathologic features and smokingSuleeporn Sangrajrang, Adisak Sornprom, Gun Chernrungroj, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|March 7, 2022
Landscape of TP53 Alterations in Chronic Lymphocytic Leukemia <i>via</i> Data Mining Mutation DatabasesThierry Soussi, Panagiotis Baliakas
Journal of Internal Medicine|June 17, 2025
The TP53 tumor suppressor gene: From molecular biology to clinical investigationsPanagiotis Baliakas, Thierry Soussi
Trends in Cell Biology|November 22, 2016
TP53 and 53BP1 ReunitedThierry Soussi, Guido Kroemer
Trends in Molecular Medicine|December 23, 2008
When mutant p53 plays hide and seek: a new challenge for diagnosis and therapy?Thierry Soussi, Linn Hjortsberg
Cancer Cell|October 16, 2007
Shaping genetic alterations in human cancer: the p53 mutation paradigmThierry Soussi, Klas G Wiman
Human Mutation|March 26, 2014
TP53 mutations in human cancer: database reassessment and prospects for the next decadeBernard Leroy, Martha Anderson, Thierry Soussi
The FEBS Journal|June 30, 2009
Investigation and prediction of the severity of p53 mutants using parameters from structural calculationsJonas Carlsson, Thierry Soussi, Bengt Persson
Oncogene|August 7, 2003
Data mining the p53 pathway in the Fugu genome: evidence for strong conservation of the apoptotic pathwayMorgane Le Bras, Karim Bensaad, Thierry Soussi
Cell Death and Differentiation|October 24, 2024
TP53: the unluckiest of genes?Andreas C Joerger, Thorsten Stiewe, Thierry Soussi
Lung Cancer (Amsterdam, Netherlands)|March 1, 2003
Serum p53 antibodies in patients with lung cancer: correlation with clinicopathologic features and smokingSuleeporn Sangrajrang, Adisak Sornprom, Gun Chernrungroj, et al.
Pageof 7